Cargando…

Modeling human yolk sac hematopoiesis with pluripotent stem cells

In the mouse, the first hematopoietic cells are generated in the yolk sac from the primitive, erythro-myeloid progenitor (EMP) and lymphoid programs that are specified before the emergence of hematopoietic stem cells. While many of the yolk sac–derived populations are transient, specific immune cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Atkins, Michael H., Scarfò, Rebecca, McGrath, Kathleen E., Yang, Donghe, Palis, James, Ditadi, Andrea, Keller, Gordon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693237/
https://www.ncbi.nlm.nih.gov/pubmed/34928315
http://dx.doi.org/10.1084/jem.20211924
_version_ 1784619103908003840
author Atkins, Michael H.
Scarfò, Rebecca
McGrath, Kathleen E.
Yang, Donghe
Palis, James
Ditadi, Andrea
Keller, Gordon M.
author_facet Atkins, Michael H.
Scarfò, Rebecca
McGrath, Kathleen E.
Yang, Donghe
Palis, James
Ditadi, Andrea
Keller, Gordon M.
author_sort Atkins, Michael H.
collection PubMed
description In the mouse, the first hematopoietic cells are generated in the yolk sac from the primitive, erythro-myeloid progenitor (EMP) and lymphoid programs that are specified before the emergence of hematopoietic stem cells. While many of the yolk sac–derived populations are transient, specific immune cell progeny seed developing tissues, where they function into adult life. To access the human equivalent of these lineages, we modeled yolk sac hematopoietic development using pluripotent stem cell differentiation. Here, we show that the combination of Activin A, BMP4, and FGF2 induces a population of KDR(+)CD235a/b(+) mesoderm that gives rise to the spectrum of erythroid, myeloid, and T lymphoid lineages characteristic of the mouse yolk sac hematopoietic programs, including the Vδ2(+) subset of γ/δ T cells that develops early in the human embryo. Through clonal analyses, we identified a multipotent hematopoietic progenitor with erythroid, myeloid, and T lymphoid potential, suggesting that the yolk sac EMP and lymphoid lineages may develop from a common progenitor.
format Online
Article
Text
id pubmed-8693237
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-86932372022-09-07 Modeling human yolk sac hematopoiesis with pluripotent stem cells Atkins, Michael H. Scarfò, Rebecca McGrath, Kathleen E. Yang, Donghe Palis, James Ditadi, Andrea Keller, Gordon M. J Exp Med Article In the mouse, the first hematopoietic cells are generated in the yolk sac from the primitive, erythro-myeloid progenitor (EMP) and lymphoid programs that are specified before the emergence of hematopoietic stem cells. While many of the yolk sac–derived populations are transient, specific immune cell progeny seed developing tissues, where they function into adult life. To access the human equivalent of these lineages, we modeled yolk sac hematopoietic development using pluripotent stem cell differentiation. Here, we show that the combination of Activin A, BMP4, and FGF2 induces a population of KDR(+)CD235a/b(+) mesoderm that gives rise to the spectrum of erythroid, myeloid, and T lymphoid lineages characteristic of the mouse yolk sac hematopoietic programs, including the Vδ2(+) subset of γ/δ T cells that develops early in the human embryo. Through clonal analyses, we identified a multipotent hematopoietic progenitor with erythroid, myeloid, and T lymphoid potential, suggesting that the yolk sac EMP and lymphoid lineages may develop from a common progenitor. Rockefeller University Press 2021-12-20 /pmc/articles/PMC8693237/ /pubmed/34928315 http://dx.doi.org/10.1084/jem.20211924 Text en © 2021 Atkins et al. https://creativecommons.org/licenses/by-nc-sa/4.0/http://www.rupress.org/terms/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Atkins, Michael H.
Scarfò, Rebecca
McGrath, Kathleen E.
Yang, Donghe
Palis, James
Ditadi, Andrea
Keller, Gordon M.
Modeling human yolk sac hematopoiesis with pluripotent stem cells
title Modeling human yolk sac hematopoiesis with pluripotent stem cells
title_full Modeling human yolk sac hematopoiesis with pluripotent stem cells
title_fullStr Modeling human yolk sac hematopoiesis with pluripotent stem cells
title_full_unstemmed Modeling human yolk sac hematopoiesis with pluripotent stem cells
title_short Modeling human yolk sac hematopoiesis with pluripotent stem cells
title_sort modeling human yolk sac hematopoiesis with pluripotent stem cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693237/
https://www.ncbi.nlm.nih.gov/pubmed/34928315
http://dx.doi.org/10.1084/jem.20211924
work_keys_str_mv AT atkinsmichaelh modelinghumanyolksachematopoiesiswithpluripotentstemcells
AT scarforebecca modelinghumanyolksachematopoiesiswithpluripotentstemcells
AT mcgrathkathleene modelinghumanyolksachematopoiesiswithpluripotentstemcells
AT yangdonghe modelinghumanyolksachematopoiesiswithpluripotentstemcells
AT palisjames modelinghumanyolksachematopoiesiswithpluripotentstemcells
AT ditadiandrea modelinghumanyolksachematopoiesiswithpluripotentstemcells
AT kellergordonm modelinghumanyolksachematopoiesiswithpluripotentstemcells